Mode
Text Size
Log in / Sign up
Phase 4 N=1,270 Randomized Treatment

Smoking Cessation in Hospitalized Smokers

Smoking Cessation

Enrolled (actual)
1,270
Serious AEs
24.4%
Results posted
Nov 2017
Primary outcome: Primary: Percentage of Participants With 30-day Abstinence — 18.0; 23.4; 22.1; 18.7 percentage of participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Nicotine Patches (Drug); Telephone Counseling (Behavioral); Brief Hospital Counseling (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Diego
Primary completion
Jul 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants With 30-day Abstinence
18.0; 23.4; 22.1; 18.7
SECONDARY
Percentage of Smokers Making a 24-hour Quit Attempt
70.0; 78.9; 77.6; 69.7
SECONDARY
Self-reported Re-hospitalization
45; 50; 53; 51
SECONDARY
30-day Abstinence
19.6; 22.5; 24.0; 18.4

Summary

When smokers are hospitalized they quit smoking, either voluntarily or involuntarily. Most of them, however, go back to smoking soon after discharge. This study will test an innovative approach which includes dispensing nicotine patches at discharge, providing proactive telephone counseling post discharge, or giving a combination of the two. The interventions are aimed at increasing the long term quit rate of these patients. The specific aims of the study are to demonstrate the effects of two interventions, dispensing nicotine patches at discharge and providing proactive telephone counseling soon after discharge, on 12-month quit rates of hospitalized smokers in a 2 x 2 factorial design.

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • Smoke >=6 Cigarettes per day
  • English or Spanish speaking
  • Valid phone number
  • Valid address
  • Gave consent to participate in study and evaluation

Exclusion Criteria

  • Hospital stay of less than 24 hours
  • Inability to communicate orally
  • Hypersensitivity to nicotine
  • Pregnant
  • Hospitalized for psychiatric treatment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01289275). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search